Global Rare Disease Therapeutic Market Growth (Status and Outlook) 2023-2029

December 2023 | 108 pages | ID: G92E465C7045EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

According to our LPI (LP Information) latest study, the global Rare Disease Therapeutic market size was valued at US$ million in 2022. With growing demand in downstream market, the Rare Disease Therapeutic is forecast to a readjusted size of US$ million by 2029 with a CAGR of % during review period.

The research report highlights the growth potential of the global Rare Disease Therapeutic market. Rare Disease Therapeutic are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Rare Disease Therapeutic. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Rare Disease Therapeutic market.

There's been a significant push in the pharmaceutical industry to develop therapies for rare diseases, often termed 'orphan drugs.' Governments in many regions, like the US and EU, offer incentives to companies developing these treatments. The market is seen as lucrative due to high drug pricing potential, even with a smaller patient population.

Key Features:

The report on Rare Disease Therapeutic market reflects various aspects and provide valuable insights into the industry.

Market Size and Growth: The research report provide an overview of the current size and growth of the Rare Disease Therapeutic market. It may include historical data, market segmentation by Type (e.g., Biologics, Biosimilar), and regional breakdowns.

Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Rare Disease Therapeutic market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.

Competitive Landscape: The research report provides analysis of the competitive landscape within the Rare Disease Therapeutic market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.

Technological Developments: The research report can delve into the latest technological developments in the Rare Disease Therapeutic industry. This include advancements in Rare Disease Therapeutic technology, Rare Disease Therapeutic new entrants, Rare Disease Therapeutic new investment, and other innovations that are shaping the future of Rare Disease Therapeutic.

Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Rare Disease Therapeutic market. It includes factors influencing customer ' purchasing decisions, preferences for Rare Disease Therapeutic product.

Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Rare Disease Therapeutic market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Rare Disease Therapeutic market. The report also evaluates the effectiveness of these policies in driving market growth.

Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Rare Disease Therapeutic market.

Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Rare Disease Therapeutic industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.

Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Rare Disease Therapeutic market.

Market Segmentation:

Rare Disease Therapeutic market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Segmentation by type

• Biologics
• Biosimilar
• Small Molecules

Segmentation by application

• Hematologic Disease
• Cancer
• Infectious Disease
• Cardiovascular Disease
• Metabolic Disease
• Endocrine Disease
• Musculoskeletal Disease
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Bristol-Myers Squibb
• Bayer
• AstraZeneca
• Pfizer
• Novo Nordisk A/S
• Sanofi SA
• AbbVie
• F Hoffmann-La Roche
• Amgen
• Eisai
• Novartis AG

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Rare Disease Therapeutic Market Size 2018-2029
  2.1.2 Rare Disease Therapeutic Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Rare Disease Therapeutic Segment by Type
  2.2.1 Biologics
  2.2.2 Biosimilar
  2.2.3 Small Molecules
2.3 Rare Disease Therapeutic Market Size by Type
  2.3.1 Rare Disease Therapeutic Market Size CAGR by Type (2018 VS 2022 VS 2029)
  2.3.2 Global Rare Disease Therapeutic Market Size Market Share by Type (2018-2023)
2.4 Rare Disease Therapeutic Segment by Application
  2.4.1 Hematologic Disease
  2.4.2 Cancer
  2.4.3 Infectious Disease
  2.4.4 Cardiovascular Disease
  2.4.5 Metabolic Disease
  2.4.6 Endocrine Disease
  2.4.7 Musculoskeletal Disease
  2.4.8 Others
2.5 Rare Disease Therapeutic Market Size by Application
  2.5.1 Rare Disease Therapeutic Market Size CAGR by Application (2018 VS 2022 VS 2029)
  2.5.2 Global Rare Disease Therapeutic Market Size Market Share by Application (2018-2023)

3 RARE DISEASE THERAPEUTIC MARKET SIZE BY PLAYER

3.1 Rare Disease Therapeutic Market Size Market Share by Players
  3.1.1 Global Rare Disease Therapeutic Revenue by Players (2018-2023)
  3.1.2 Global Rare Disease Therapeutic Revenue Market Share by Players (2018-2023)
3.2 Global Rare Disease Therapeutic Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 RARE DISEASE THERAPEUTIC BY REGIONS

4.1 Rare Disease Therapeutic Market Size by Regions (2018-2023)
4.2 Americas Rare Disease Therapeutic Market Size Growth (2018-2023)
4.3 APAC Rare Disease Therapeutic Market Size Growth (2018-2023)
4.4 Europe Rare Disease Therapeutic Market Size Growth (2018-2023)
4.5 Middle East & Africa Rare Disease Therapeutic Market Size Growth (2018-2023)

5 AMERICAS

5.1 Americas Rare Disease Therapeutic Market Size by Country (2018-2023)
5.2 Americas Rare Disease Therapeutic Market Size by Type (2018-2023)
5.3 Americas Rare Disease Therapeutic Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Rare Disease Therapeutic Market Size by Region (2018-2023)
6.2 APAC Rare Disease Therapeutic Market Size by Type (2018-2023)
6.3 APAC Rare Disease Therapeutic Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Rare Disease Therapeutic by Country (2018-2023)
7.2 Europe Rare Disease Therapeutic Market Size by Type (2018-2023)
7.3 Europe Rare Disease Therapeutic Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Rare Disease Therapeutic by Region (2018-2023)
8.2 Middle East & Africa Rare Disease Therapeutic Market Size by Type (2018-2023)
8.3 Middle East & Africa Rare Disease Therapeutic Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL RARE DISEASE THERAPEUTIC MARKET FORECAST

10.1 Global Rare Disease Therapeutic Forecast by Regions (2024-2029)
  10.1.1 Global Rare Disease Therapeutic Forecast by Regions (2024-2029)
  10.1.2 Americas Rare Disease Therapeutic Forecast
  10.1.3 APAC Rare Disease Therapeutic Forecast
  10.1.4 Europe Rare Disease Therapeutic Forecast
  10.1.5 Middle East & Africa Rare Disease Therapeutic Forecast
10.2 Americas Rare Disease Therapeutic Forecast by Country (2024-2029)
  10.2.1 United States Rare Disease Therapeutic Market Forecast
  10.2.2 Canada Rare Disease Therapeutic Market Forecast
  10.2.3 Mexico Rare Disease Therapeutic Market Forecast
  10.2.4 Brazil Rare Disease Therapeutic Market Forecast
10.3 APAC Rare Disease Therapeutic Forecast by Region (2024-2029)
  10.3.1 China Rare Disease Therapeutic Market Forecast
  10.3.2 Japan Rare Disease Therapeutic Market Forecast
  10.3.3 Korea Rare Disease Therapeutic Market Forecast
  10.3.4 Southeast Asia Rare Disease Therapeutic Market Forecast
  10.3.5 India Rare Disease Therapeutic Market Forecast
  10.3.6 Australia Rare Disease Therapeutic Market Forecast
10.4 Europe Rare Disease Therapeutic Forecast by Country (2024-2029)
  10.4.1 Germany Rare Disease Therapeutic Market Forecast
  10.4.2 France Rare Disease Therapeutic Market Forecast
  10.4.3 UK Rare Disease Therapeutic Market Forecast
  10.4.4 Italy Rare Disease Therapeutic Market Forecast
  10.4.5 Russia Rare Disease Therapeutic Market Forecast
10.5 Middle East & Africa Rare Disease Therapeutic Forecast by Region (2024-2029)
  10.5.1 Egypt Rare Disease Therapeutic Market Forecast
  10.5.2 South Africa Rare Disease Therapeutic Market Forecast
  10.5.3 Israel Rare Disease Therapeutic Market Forecast
  10.5.4 Turkey Rare Disease Therapeutic Market Forecast
  10.5.5 GCC Countries Rare Disease Therapeutic Market Forecast
10.6 Global Rare Disease Therapeutic Forecast by Type (2024-2029)
10.7 Global Rare Disease Therapeutic Forecast by Application (2024-2029)

11 KEY PLAYERS ANALYSIS

11.1 Bristol-Myers Squibb
  11.1.1 Bristol-Myers Squibb Company Information
  11.1.2 Bristol-Myers Squibb Rare Disease Therapeutic Product Offered
  11.1.3 Bristol-Myers Squibb Rare Disease Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
  11.1.4 Bristol-Myers Squibb Main Business Overview
  11.1.5 Bristol-Myers Squibb Latest Developments
11.2 Bayer
  11.2.1 Bayer Company Information
  11.2.2 Bayer Rare Disease Therapeutic Product Offered
  11.2.3 Bayer Rare Disease Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
  11.2.4 Bayer Main Business Overview
  11.2.5 Bayer Latest Developments
11.3 AstraZeneca
  11.3.1 AstraZeneca Company Information
  11.3.2 AstraZeneca Rare Disease Therapeutic Product Offered
  11.3.3 AstraZeneca Rare Disease Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
  11.3.4 AstraZeneca Main Business Overview
  11.3.5 AstraZeneca Latest Developments
11.4 Pfizer
  11.4.1 Pfizer Company Information
  11.4.2 Pfizer Rare Disease Therapeutic Product Offered
  11.4.3 Pfizer Rare Disease Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
  11.4.4 Pfizer Main Business Overview
  11.4.5 Pfizer Latest Developments
11.5 Novo Nordisk A/S
  11.5.1 Novo Nordisk A/S Company Information
  11.5.2 Novo Nordisk A/S Rare Disease Therapeutic Product Offered
  11.5.3 Novo Nordisk A/S Rare Disease Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
  11.5.4 Novo Nordisk A/S Main Business Overview
  11.5.5 Novo Nordisk A/S Latest Developments
11.6 Sanofi SA
  11.6.1 Sanofi SA Company Information
  11.6.2 Sanofi SA Rare Disease Therapeutic Product Offered
  11.6.3 Sanofi SA Rare Disease Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
  11.6.4 Sanofi SA Main Business Overview
  11.6.5 Sanofi SA Latest Developments
11.7 AbbVie
  11.7.1 AbbVie Company Information
  11.7.2 AbbVie Rare Disease Therapeutic Product Offered
  11.7.3 AbbVie Rare Disease Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
  11.7.4 AbbVie Main Business Overview
  11.7.5 AbbVie Latest Developments
11.8 F Hoffmann-La Roche
  11.8.1 F Hoffmann-La Roche Company Information
  11.8.2 F Hoffmann-La Roche Rare Disease Therapeutic Product Offered
  11.8.3 F Hoffmann-La Roche Rare Disease Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
  11.8.4 F Hoffmann-La Roche Main Business Overview
  11.8.5 F Hoffmann-La Roche Latest Developments
11.9 Amgen
  11.9.1 Amgen Company Information
  11.9.2 Amgen Rare Disease Therapeutic Product Offered
  11.9.3 Amgen Rare Disease Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
  11.9.4 Amgen Main Business Overview
  11.9.5 Amgen Latest Developments
11.10 Eisai
  11.10.1 Eisai Company Information
  11.10.2 Eisai Rare Disease Therapeutic Product Offered
  11.10.3 Eisai Rare Disease Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
  11.10.4 Eisai Main Business Overview
  11.10.5 Eisai Latest Developments
11.11 Novartis AG
  11.11.1 Novartis AG Company Information
  11.11.2 Novartis AG Rare Disease Therapeutic Product Offered
  11.11.3 Novartis AG Rare Disease Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
  11.11.4 Novartis AG Main Business Overview
  11.11.5 Novartis AG Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Rare Disease Therapeutic Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Biologics
Table 3. Major Players of Biosimilar
Table 4. Major Players of Small Molecules
Table 5. Rare Disease Therapeutic Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 6. Global Rare Disease Therapeutic Market Size by Type (2018-2023) & ($ Millions)
Table 7. Global Rare Disease Therapeutic Market Size Market Share by Type (2018-2023)
Table 8. Rare Disease Therapeutic Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 9. Global Rare Disease Therapeutic Market Size by Application (2018-2023) & ($ Millions)
Table 10. Global Rare Disease Therapeutic Market Size Market Share by Application (2018-2023)
Table 11. Global Rare Disease Therapeutic Revenue by Players (2018-2023) & ($ Millions)
Table 12. Global Rare Disease Therapeutic Revenue Market Share by Player (2018-2023)
Table 13. Rare Disease Therapeutic Key Players Head office and Products Offered
Table 14. Rare Disease Therapeutic Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Rare Disease Therapeutic Market Size by Regions 2018-2023 & ($ Millions)
Table 18. Global Rare Disease Therapeutic Market Size Market Share by Regions (2018-2023)
Table 19. Global Rare Disease Therapeutic Revenue by Country/Region (2018-2023) & ($ millions)
Table 20. Global Rare Disease Therapeutic Revenue Market Share by Country/Region (2018-2023)
Table 21. Americas Rare Disease Therapeutic Market Size by Country (2018-2023) & ($ Millions)
Table 22. Americas Rare Disease Therapeutic Market Size Market Share by Country (2018-2023)
Table 23. Americas Rare Disease Therapeutic Market Size by Type (2018-2023) & ($ Millions)
Table 24. Americas Rare Disease Therapeutic Market Size Market Share by Type (2018-2023)
Table 25. Americas Rare Disease Therapeutic Market Size by Application (2018-2023) & ($ Millions)
Table 26. Americas Rare Disease Therapeutic Market Size Market Share by Application (2018-2023)
Table 27. APAC Rare Disease Therapeutic Market Size by Region (2018-2023) & ($ Millions)
Table 28. APAC Rare Disease Therapeutic Market Size Market Share by Region (2018-2023)
Table 29. APAC Rare Disease Therapeutic Market Size by Type (2018-2023) & ($ Millions)
Table 30. APAC Rare Disease Therapeutic Market Size Market Share by Type (2018-2023)
Table 31. APAC Rare Disease Therapeutic Market Size by Application (2018-2023) & ($ Millions)
Table 32. APAC Rare Disease Therapeutic Market Size Market Share by Application (2018-2023)
Table 33. Europe Rare Disease Therapeutic Market Size by Country (2018-2023) & ($ Millions)
Table 34. Europe Rare Disease Therapeutic Market Size Market Share by Country (2018-2023)
Table 35. Europe Rare Disease Therapeutic Market Size by Type (2018-2023) & ($ Millions)
Table 36. Europe Rare Disease Therapeutic Market Size Market Share by Type (2018-2023)
Table 37. Europe Rare Disease Therapeutic Market Size by Application (2018-2023) & ($ Millions)
Table 38. Europe Rare Disease Therapeutic Market Size Market Share by Application (2018-2023)
Table 39. Middle East & Africa Rare Disease Therapeutic Market Size by Region (2018-2023) & ($ Millions)
Table 40. Middle East & Africa Rare Disease Therapeutic Market Size Market Share by Region (2018-2023)
Table 41. Middle East & Africa Rare Disease Therapeutic Market Size by Type (2018-2023) & ($ Millions)
Table 42. Middle East & Africa Rare Disease Therapeutic Market Size Market Share by Type (2018-2023)
Table 43. Middle East & Africa Rare Disease Therapeutic Market Size by Application (2018-2023) & ($ Millions)
Table 44. Middle East & Africa Rare Disease Therapeutic Market Size Market Share by Application (2018-2023)
Table 45. Key Market Drivers & Growth Opportunities of Rare Disease Therapeutic
Table 46. Key Market Challenges & Risks of Rare Disease Therapeutic
Table 47. Key Industry Trends of Rare Disease Therapeutic
Table 48. Global Rare Disease Therapeutic Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 49. Global Rare Disease Therapeutic Market Size Market Share Forecast by Regions (2024-2029)
Table 50. Global Rare Disease Therapeutic Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 51. Global Rare Disease Therapeutic Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 52. Bristol-Myers Squibb Details, Company Type, Rare Disease Therapeutic Area Served and Its Competitors
Table 53. Bristol-Myers Squibb Rare Disease Therapeutic Product Offered
Table 54. Bristol-Myers Squibb Rare Disease Therapeutic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 55. Bristol-Myers Squibb Main Business
Table 56. Bristol-Myers Squibb Latest Developments
Table 57. Bayer Details, Company Type, Rare Disease Therapeutic Area Served and Its Competitors
Table 58. Bayer Rare Disease Therapeutic Product Offered
Table 59. Bayer Main Business
Table 60. Bayer Rare Disease Therapeutic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 61. Bayer Latest Developments
Table 62. AstraZeneca Details, Company Type, Rare Disease Therapeutic Area Served and Its Competitors
Table 63. AstraZeneca Rare Disease Therapeutic Product Offered
Table 64. AstraZeneca Main Business
Table 65. AstraZeneca Rare Disease Therapeutic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 66. AstraZeneca Latest Developments
Table 67. Pfizer Details, Company Type, Rare Disease Therapeutic Area Served and Its Competitors
Table 68. Pfizer Rare Disease Therapeutic Product Offered
Table 69. Pfizer Main Business
Table 70. Pfizer Rare Disease Therapeutic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 71. Pfizer Latest Developments
Table 72. Novo Nordisk A/S Details, Company Type, Rare Disease Therapeutic Area Served and Its Competitors
Table 73. Novo Nordisk A/S Rare Disease Therapeutic Product Offered
Table 74. Novo Nordisk A/S Main Business
Table 75. Novo Nordisk A/S Rare Disease Therapeutic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 76. Novo Nordisk A/S Latest Developments
Table 77. Sanofi SA Details, Company Type, Rare Disease Therapeutic Area Served and Its Competitors
Table 78. Sanofi SA Rare Disease Therapeutic Product Offered
Table 79. Sanofi SA Main Business
Table 80. Sanofi SA Rare Disease Therapeutic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 81. Sanofi SA Latest Developments
Table 82. AbbVie Details, Company Type, Rare Disease Therapeutic Area Served and Its Competitors
Table 83. AbbVie Rare Disease Therapeutic Product Offered
Table 84. AbbVie Main Business
Table 85. AbbVie Rare Disease Therapeutic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 86. AbbVie Latest Developments
Table 87. F Hoffmann-La Roche Details, Company Type, Rare Disease Therapeutic Area Served and Its Competitors
Table 88. F Hoffmann-La Roche Rare Disease Therapeutic Product Offered
Table 89. F Hoffmann-La Roche Main Business
Table 90. F Hoffmann-La Roche Rare Disease Therapeutic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 91. F Hoffmann-La Roche Latest Developments
Table 92. Amgen Details, Company Type, Rare Disease Therapeutic Area Served and Its Competitors
Table 93. Amgen Rare Disease Therapeutic Product Offered
Table 94. Amgen Main Business
Table 95. Amgen Rare Disease Therapeutic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 96. Amgen Latest Developments
Table 97. Eisai Details, Company Type, Rare Disease Therapeutic Area Served and Its Competitors
Table 98. Eisai Rare Disease Therapeutic Product Offered
Table 99. Eisai Main Business
Table 100. Eisai Rare Disease Therapeutic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 101. Eisai Latest Developments
Table 102. Novartis AG Details, Company Type, Rare Disease Therapeutic Area Served and Its Competitors
Table 103. Novartis AG Rare Disease Therapeutic Product Offered
Table 104. Novartis AG Rare Disease Therapeutic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 105. Novartis AG Main Business
Table 106. Novartis AG Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Rare Disease Therapeutic Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Rare Disease Therapeutic Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Rare Disease Therapeutic Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Rare Disease Therapeutic Sales Market Share by Country/Region (2022)
Figure 8. Rare Disease Therapeutic Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Rare Disease Therapeutic Market Size Market Share by Type in 2022
Figure 10. Rare Disease Therapeutic in Hematologic Disease
Figure 11. Global Rare Disease Therapeutic Market: Hematologic Disease (2018-2023) & ($ Millions)
Figure 12. Rare Disease Therapeutic in Cancer
Figure 13. Global Rare Disease Therapeutic Market: Cancer (2018-2023) & ($ Millions)
Figure 14. Rare Disease Therapeutic in Infectious Disease
Figure 15. Global Rare Disease Therapeutic Market: Infectious Disease (2018-2023) & ($ Millions)
Figure 16. Rare Disease Therapeutic in Cardiovascular Disease
Figure 17. Global Rare Disease Therapeutic Market: Cardiovascular Disease (2018-2023) & ($ Millions)
Figure 18. Rare Disease Therapeutic in Metabolic Disease
Figure 19. Global Rare Disease Therapeutic Market: Metabolic Disease (2018-2023) & ($ Millions)
Figure 20. Rare Disease Therapeutic in Endocrine Disease
Figure 21. Global Rare Disease Therapeutic Market: Endocrine Disease (2018-2023) & ($ Millions)
Figure 22. Rare Disease Therapeutic in Musculoskeletal Disease
Figure 23. Global Rare Disease Therapeutic Market: Musculoskeletal Disease (2018-2023) & ($ Millions)
Figure 24. Rare Disease Therapeutic in Others
Figure 25. Global Rare Disease Therapeutic Market: Others (2018-2023) & ($ Millions)
Figure 26. Global Rare Disease Therapeutic Market Size Market Share by Application in 2022
Figure 27. Global Rare Disease Therapeutic Revenue Market Share by Player in 2022
Figure 28. Global Rare Disease Therapeutic Market Size Market Share by Regions (2018-2023)
Figure 29. Americas Rare Disease Therapeutic Market Size 2018-2023 ($ Millions)
Figure 30. APAC Rare Disease Therapeutic Market Size 2018-2023 ($ Millions)
Figure 31. Europe Rare Disease Therapeutic Market Size 2018-2023 ($ Millions)
Figure 32. Middle East & Africa Rare Disease Therapeutic Market Size 2018-2023 ($ Millions)
Figure 33. Americas Rare Disease Therapeutic Value Market Share by Country in 2022
Figure 34. United States Rare Disease Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 35. Canada Rare Disease Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 36. Mexico Rare Disease Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 37. Brazil Rare Disease Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 38. APAC Rare Disease Therapeutic Market Size Market Share by Region in 2022
Figure 39. APAC Rare Disease Therapeutic Market Size Market Share by Type in 2022
Figure 40. APAC Rare Disease Therapeutic Market Size Market Share by Application in 2022
Figure 41. China Rare Disease Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 42. Japan Rare Disease Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 43. Korea Rare Disease Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 44. Southeast Asia Rare Disease Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 45. India Rare Disease Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 46. Australia Rare Disease Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 47. Europe Rare Disease Therapeutic Market Size Market Share by Country in 2022
Figure 48. Europe Rare Disease Therapeutic Market Size Market Share by Type (2018-2023)
Figure 49. Europe Rare Disease Therapeutic Market Size Market Share by Application (2018-2023)
Figure 50. Germany Rare Disease Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 51. France Rare Disease Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 52. UK Rare Disease Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 53. Italy Rare Disease Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 54. Russia Rare Disease Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 55. Middle East & Africa Rare Disease Therapeutic Market Size Market Share by Region (2018-2023)
Figure 56. Middle East & Africa Rare Disease Therapeutic Market Size Market Share by Type (2018-2023)
Figure 57. Middle East & Africa Rare Disease Therapeutic Market Size Market Share by Application (2018-2023)
Figure 58. Egypt Rare Disease Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 59. South Africa Rare Disease Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 60. Israel Rare Disease Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 61. Turkey Rare Disease Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 62. GCC Country Rare Disease Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 63. Americas Rare Disease Therapeutic Market Size 2024-2029 ($ Millions)
Figure 64. APAC Rare Disease Therapeutic Market Size 2024-2029 ($ Millions)
Figure 65. Europe Rare Disease Therapeutic Market Size 2024-2029 ($ Millions)
Figure 66. Middle East & Africa Rare Disease Therapeutic Market Size 2024-2029 ($ Millions)
Figure 67. United States Rare Disease Therapeutic Market Size 2024-2029 ($ Millions)
Figure 68. Canada Rare Disease Therapeutic Market Size 2024-2029 ($ Millions)
Figure 69. Mexico Rare Disease Therapeutic Market Size 2024-2029 ($ Millions)
Figure 70. Brazil Rare Disease Therapeutic Market Size 2024-2029 ($ Millions)
Figure 71. China Rare Disease Therapeutic Market Size 2024-2029 ($ Millions)
Figure 72. Japan Rare Disease Therapeutic Market Size 2024-2029 ($ Millions)
Figure 73. Korea Rare Disease Therapeutic Market Size 2024-2029 ($ Millions)
Figure 74. Southeast Asia Rare Disease Therapeutic Market Size 2024-2029 ($ Millions)
Figure 75. India Rare Disease Therapeutic Market Size 2024-2029 ($ Millions)
Figure 76. Australia Rare Disease Therapeutic Market Size 2024-2029 ($ Millions)
Figure 77. Germany Rare Disease Therapeutic Market Size 2024-2029 ($ Millions)
Figure 78. France Rare Disease Therapeutic Market Size 2024-2029 ($ Millions)
Figure 79. UK Rare Disease Therapeutic Market Size 2024-2029 ($ Millions)
Figure 80. Italy Rare Disease Therapeutic Market Size 2024-2029 ($ Millions)
Figure 81. Russia Rare Disease Therapeutic Market Size 2024-2029 ($ Millions)
Figure 82. Spain Rare Disease Therapeutic Market Size 2024-2029 ($ Millions)
Figure 83. Egypt Rare Disease Therapeutic Market Size 2024-2029 ($ Millions)
Figure 84. South Africa Rare Disease Therapeutic Market Size 2024-2029 ($ Millions)
Figure 85. Israel Rare Disease Therapeutic Market Size 2024-2029 ($ Millions)
Figure 86. Turkey Rare Disease Therapeutic Market Size 2024-2029 ($ Millions)
Figure 87. GCC Countries Rare Disease Therapeutic Market Size 2024-2029 ($ Millions)
Figure 88. Global Rare Disease Therapeutic Market Size Market Share Forecast by Type (2024-2029)
Figure 89. Global Rare Disease Therapeutic Market Size Market Share Forecast by Application (2024-2029)